16-89920090-A-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_002386.4(MC1R):āc.832A>Gā(p.Lys278Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000304 in 1,613,762 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002386.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MC1R | NM_002386.4 | c.832A>G | p.Lys278Glu | missense_variant | 1/1 | ENST00000555147.2 | NP_002377.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC1R | ENST00000555147.2 | c.832A>G | p.Lys278Glu | missense_variant | 1/1 | NM_002386.4 | ENSP00000451605 | P1 | ||
ENST00000554623.1 | n.722T>C | non_coding_transcript_exon_variant | 2/2 | 3 | ||||||
MC1R | ENST00000555427.1 | c.832A>G | p.Lys278Glu | missense_variant | 3/4 | 5 | ENSP00000451760 | |||
MC1R | ENST00000639847.1 | c.832A>G | p.Lys278Glu | missense_variant | 3/3 | 5 | ENSP00000492011 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000429 AC: 107AN: 249224Hom.: 0 AF XY: 0.000451 AC XY: 61AN XY: 135216
GnomAD4 exome AF: 0.000312 AC: 456AN: 1461594Hom.: 1 Cov.: 35 AF XY: 0.000319 AC XY: 232AN XY: 727084
GnomAD4 genome AF: 0.000223 AC: 34AN: 152168Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74330
ClinVar
Submissions by phenotype
Melanoma, cutaneous malignant, susceptibility to, 5 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 25, 2023 | This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 278 of the MC1R protein (p.Lys278Glu). This variant is present in population databases (rs201171524, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with melanoma (PMID: 15221796, 15998953, 16601669, 16982779, 17434924, 18983535, 24982914). ClinVar contains an entry for this variant (Variation ID: 406214). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MC1R protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Increased analgesia from kappa-opioid receptor agonist, female-specific Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 05, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at